1059 related articles for article (PubMed ID: 26892923)
1. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
3. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
Chuang CP; Jong YS; Wu CY; Lo HM
Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111
[TBL] [Abstract][Full Text] [Related]
4. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
6. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
12. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
[TBL] [Abstract][Full Text] [Related]
14. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A
Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.
März W; Tiran B; Seelhorst U; Wellnitz B; Bauersachs J; Winkelmann BR; Boehm BO;
Clin Chem; 2007 Jun; 53(6):1075-83. PubMed ID: 17446333
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
17. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
[TBL] [Abstract][Full Text] [Related]
18. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
Li X; Chen C; Gan F; Wang Y; Ding L; Hua W
BMC Cardiovasc Disord; 2014 May; 14():67. PubMed ID: 24885051
[TBL] [Abstract][Full Text] [Related]
19. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
[TBL] [Abstract][Full Text] [Related]
20. Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure.
Nishino M; Kimura T; Kanda T; Kotajima N; Yoshida A; Kuwabara A; Tamama K; Fukumura Y; Kobayashi I
J Endocrinol Invest; 2000 Sep; 23(8):509-14. PubMed ID: 11021766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
